FDA Antioxidants Claim Review Improperly Focused On Prevention - Lawsuit
This article was originally published in The Tan Sheet
Executive Summary
FDA inappropriately focused on cancer-prevention evidence in denying a proposed dietary supplement health claim for antioxidant vitamins and cancer risk reduction, supplement firms say in a lawsuit filed against the agency July 16.
You may also be interested in...
Phosphatidylserine, Dementia, Cognitive Decline Health Claim Sought
No particular dose of phosphatidylserine works better at reducing the severity of cognitive dysfunction and the risk of dementia, according to a health claim petition filed with FDA April 19
Phosphatidylserine, Dementia, Cognitive Decline Health Claim Sought
No particular dose of phosphatidylserine works better at reducing the severity of cognitive dysfunction and the risk of dementia, according to a health claim petition filed with FDA April 19
Phosphatidylserine, Dementia, Cognitive Decline Health Claim Sought
No particular dose of phosphatidylserine works better at reducing the severity of cognitive dysfunction and the risk of dementia, according to a health claim petition filed with FDA April 19